KAYLA BYRD: Open Payments
NPI 1710607668 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 63 payments from 18 companies in 2025. Trend: 2023 $1,082 · 2024 $1,493 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $239 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $114 |
| Xeris Pharmaceuticals, Inc. | 5 | $107 |
| Amgen Inc. | 5 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $60 |
| Tandem Diabetes Care, Inc. | 3 | $56 |
| Radius Health, Inc. | 3 | $56 |
| BETA BIONICS, INC. | 3 | $51 |
| Insulet Corporation | 2 | $45 |
| Dexcom, Inc. | 2 | $34 |
Products named: Ozempic, Kerendia, GVOKE HYPOPEN, Rybelsus, TEPEZZA, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, Tymlos.
Industry payments across AL — which companies pay providers there.
